According to Dr Mielke selective allodepletion with Atir carries significant potential for improving the outcome of mismatched (haploidentical) transplants by allowing early immune reconstitution with less severe or
LCP-Feno is designed to be an AB-rated, substitutable version of Tricor 145mg, currently marketed in the US by Abbott under the name Tricor and in Europe by Solvay
Lines of credit have been established for a continuous flow of product during the expected growth phase, ensuring that Medical Institutional Services Holdings (MIHS) will be able consistently
The study is being conducted by PhaseOneTrials, Copenhagen, and will include a maximum of 48 healthy male volunteers. The company has also announced that the first cohort of
OCuSOFT has recently introduced OCuSOFT Lid Scrub Plus for moderate to severe eyelid conditions where bacterial involvement is suspected. It is strongly recommended by physicians as a pre-surgical
One of the patents is related to the treatment of a wide range of autoimmune and inflammatory diseases such as multiple sclerosis, arthritis and psoriasis. The patent was
The Genous stent is coated with an antibody to capture a patient’s endothelial progenitor cells (EPC) circulating in the bloodstream. When attracted to the inner surface of the
The randomized, double blind, controlled Phase I trial is expected to enroll 128 healthy subjects in four treatment cohorts. The study will evaluate a licensed trivalent, inactivated, split
The private placement consisted of 10,660,705 units, each unit consisting of one share of the company’s common stock and one two-year stock purchase warrant to purchase an additional
The Lucassin rolling new drug application (NDA) submission is based on the results from OT-0401, a randomized, double-blind, multi-center, placebo-controlled Phase III study in 112 patients with hepatorenal
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.